Published today in Interface, journal of the Royal Society, the study ‘Lung cancer assistant: a hybrid clinical decision support application for lung cancer care’ describes how lung cancer assistant (LCA) can assist doctors, nurses and specialists in the multi-disciplinary team (MDT) in making treatment decisions for patients with lung cancer.
Dr Ian Woolhouse, Associate Director, National Lung Cancer Audit welcomed the study:
MDTs are common now in managing cancer care. The benefit of the MDT approach is it allows clinicians to share best practice, expertise and experience when making decisions about treatment for care. However, this does mean that there is a large amount of information to review before coming to the decision, which can be time consuming. The LCA, that these experts have developed, can assist this decision making process by consolidating the data, guidance, recommendations and expertise into one platform. This has the potential to improve the speed and quality of the clinical decisions made about the treatment and care for lung cancer patients.
For more information, please contact Hannah Bristow, Clinical Standards communications officer, on 020 3075 1447 / 07584 303 784 or email Hannah.Bristow@rcplondon.ac.uk
- The LCA has been developed through the review of two existing decision support systems - clinical guideline rules and probabilistic recommendations.
- The study is available online from the Royal Society website.